• Penn Medicine and Children’s Hospital of Philadelphia launch first CRISPR-based platform to pinpoint drivers of acute myeloid leukemia in patient cells February 25, 2026 A new toolkit allows researchers to test potential cancer targets directly in patient-leukemia cells.
• Study finds telemedicine visits cost far less than office visits February 23, 2026 In addition to being five times less costly, the telemedicine visits led to fewer follow-up visits, too.
• Penn Medicine’s Samuel Parry, MD, awarded 2026 Society of Maternal Fetal Medicine Lifetime Achievement Award February 19, 2026 Samuel Parry, MD, the Franklin Payne Professor of Obstetrics and Gynecology at Penn has been awarded the Society of Maternal Fetal Medicine (SMFM)’s 2026 Lifetime Achievement Award.
• Where peak performance meets progressive disease February 18, 2026 A muscle science lab draws on personal experience at the extremes—world-class athleticism and muscular dystrophy—in seeking a safer gene therapy.
• Could ‘cyborg’ transplants replace pancreatic tissue damaged by diabetes? February 18, 2026 A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes.

Use arrow keys to view news

Use arrow keys to view events